XML 26 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 9 - Stockholders' Equity
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
9.
         Stockholders’ Equity
 
Series B Convertible Preferred Stock
 
As of
June 30, 2018,
there are
100
shares of our Series B Convertible Preferred Stock (“Series B Preferred Stock”) outstanding. The Series B Preferred Stock
may
be converted at any time at the option of the holder into shares of our common stock at a conversion price of
$0.35
per share, or
285,714
shares. During the
six
months ended
June 
30,
2018,
there were
no
conversions or other transactions involving our Series B Preferred Stock.
 
Series C Convertible Preferred Stock
 
As of
June 30, 2018,
there are
2,570
shares of our Series C Convertible Preferred Stock (“Series C Preferred Stock”) outstanding. The Series C Preferred Stock
may
be converted at any time at the option of the holder into shares of our common stock at a conversion price of
$0.015
per share, or
171,349,733
shares. During the
six
months ended
June 
30,
2018,
there were
no
conversions or other transactions involving our Series C Preferred Stock.
 
Series D Convertible Preferred Stock
 
As of
June 30, 2018,
there are
205
shares of our Series D Convertible Preferred Stock (“Series D Preferred Stock”) outstanding. The Series D Preferred Stock
may
be converted at any time at the option of the holder into shares of our common stock at a conversion price of
$0.015
per share, or
13,666,666
shares. During the
six
months ended
June 
30,
2018,
795
shares our Series D Preferred Stock were converted into
53,000,000
shares of our common stock.
 
Series E Convertible Preferred Stock
 
In
March 2018,
we issued
600
shares of our Series E Convertible Preferred Stock,
$1,000
stated value (“Series E Preferred Stock”), for net proceeds, after deduction of certain expenses, of
$590,000.
 
Each share of Series E Preferred Stock is entitled to a liquidation preference equal to the initial purchase price, has
no
voting rights, and is
not
entitled to a dividend. The Series E Preferred Stock is convertible at any time at the option of the holders into shares of our common stock, with an initial conversion price of
$0.08
per share. The Series E Preferred Shares contains price adjustment provisions, which
may,
under certain circumstances, reduce the conversion price on future dates according to a formula based on the then-current market price for our common stock.
 
We assessed the Series E Preferred Stock under ASC Topic
480,
Distinguishing Liabilities from Equity
” (“ASC
480”
), ASC Topic
815,
Derivatives and Hedging
” (“ASC
815”
), and ASC Topic
470,
Debt
” (“ASC
470”
). The preferred stock contains an embedded feature allowing an optional conversion by the holder into common stock which meets the definition of a derivative. However, we determined that the preferred stock is an “equity host” (as described by ASC
815
) for purposes of assessing the embedded derivative for potential bifurcation and that the optional conversion feature is clearly and closely associated to the preferred stock host; therefore, the embedded derivative does
not
require bifurcation and separate recognition under ASC
815.
During the
six
months ended
June 
30,
2018,
there were
no
conversions or other transactions involving our Series E Preferred Stock
 
Common Stock Transactions
 
As discussed above, during the
six
months ended
June 30, 2018,
we issued
53,000,000
shares of our common stock pursuant to the conversion of
795
shares of our Series D Preferred Stock.
 
During the
six
months ended
June 30, 2018,
we issued
5,000,000
shares of our common stock in connection with our entering into a financial advisory and investment banking agreement (see “Stock-Based Compensation Expense” below).
 
Stock Options
 
The following table presents a summary of our stock option transactions during the
six
months ended
June 30, 2018:
 
   
 
Number of Shares
   
Weighted Average
Exercise Price
 
Outstanding at December 31, 2017
   
7,024,275
    $
0.29
 
Granted
   
--
     
--
 
Exercised
   
--
     
--
 
Forfeited or expired
   
(138,000
)    
3.01
 
Outstanding at June 30, 2018
   
6,886,275
    $
0.24
 
Exercisable at June 30, 2018
   
1,890,618
    $
0.71
 
 
Stock Purchase Warrants
 
On
February 28, 2018,
in connection with issuance of the note payable discussed in Note
7,
we issued a
five
-year warrant to purchase
178,571
shares of our common stock at a purchase price of
$0.042
per share. We had
no
other stock purchase warrants outstanding at
June 30, 2018.
 
Stock-Based Compensation Expense
 
Stock-based compensation expense related to our stock option plans was
$23,221
and
$47,199
for the
three
-month and
six
-month periods ended
June 30, 2018,
respectively, as compared to
$14,522
and
$29,102
for the
three
-month and
six
-month periods ended
June 30, 2017,
respectively. Stock-based compensation expense for stock options is recognized on a straight-line basis over the requisite service period for the award and is allocated to research and development expense or general and administrative expense based upon the related employee classification. As of
June 30, 2018,
there was
$168,503
of unrecognized compensation expense related to stock options, which we expect to recognize over a weighted average period of
2.1
years.
 
Additionally, during the
three
-month and
six
-month periods ended
June 30, 2018
we recorded stock-based compensation expense of
$57,143
and
$85,714,
respectively, associated with common stock issued for financial advisory services. As of
June 30, 2018,
there was
$114,286
of unrecognized stock-based compensation expense associated with this arrangement, which we expect to recognize during the remainder of
2018.